Paul Kayne
About Paul Kayne
Paul Kayne is the Director at Bristol-Myers Squibb, with over two decades of experience in pharmaceutical research and development.
Current Title and Role
Paul Kayne serves as a Director at Bristol-Myers Squibb. With a leadership role since 2014, he oversees significant projects and teams, contributing to the company's research and development efforts.
Professional Background
Paul Kayne has accumulated extensive experience in the pharmaceutical industry. Before his current role, he worked at Bristol-Myers Squibb as a Senior Principal Scientist from 2009 to 2014, as a Principal Scientist from 2002 to 2009 in New York, and as a Senior Research Investigator from 1999 to 2002. Prior to joining Bristol-Myers Squibb, he held positions at GSK and SmithKline Beecham Corporation.
Experience in Pharmaceutical Research
Throughout his career, Paul Kayne has played a significant role in pharmaceutical research and development. His tenure at Bristol-Myers Squibb spans over two decades, where he has held various scientific roles including Senior Principal Scientist, Principal Scientist, and Senior Research Investigator. His earlier experiences include a Senior Research Investigator position at GSK and a Research Investigator role at SmithKline Beecham Corporation.
Academic Background
Paul Kayne has a robust academic foundation in the sciences. He earned his Doctor of Philosophy from the University of California, Los Angeles, where he studied from 1982 to 1989. Prior to that, he achieved a Bachelor of Arts from UC Santa Barbara, furthering his preparation for a career in research and academia.
Transition from Academia to Industry
Paul Kayne started his career in academia as research faculty at Caltech, where he worked from 1989 to 1995. He then transitioned to the pharmaceutical industry, joining SmithKline Beecham Corporation as a Research Investigator and later moving on to senior roles at prominent companies like GSK and Bristol-Myers Squibb.